This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Feb;197(2S):S224-S225.

doi: 10.1016/j.juro.2016.11.077. Epub 2016 Dec 20.

OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence

Michael B Chancellor¹

Affiliations

PMID: 28010976
DOI: 10.1016/j.juro.2016.11.077

Comment

OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence

Michael B Chancellor. J Urol. 2017 Feb.

. 2017 Feb;197(2S):S224-S225.

doi: 10.1016/j.juro.2016.11.077. Epub 2016 Dec 20.

Author

Michael B Chancellor¹

Affiliation

¹ Department of Urology, Aikens Research Center, Beaumont Health and Oakland University, William Beaumont School of Medicine, Rochester, Minnesota.

PMID: 28010976
DOI: 10.1016/j.juro.2016.11.077

No abstract available

PubMed Disclaimer

Comment on

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group. Nitti VW, et al. J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14. J Urol. 2013. PMID: 23246476 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information